Content
02/19/2025
Vancouver Canada
Reverb Therapeutics
completed $12 million Seed Round funding. Investors include
Amplitude Ventures (lead), Multiple Myeloma Research Foundation, KdT Ventures, Finchley Healthcare Ventures, InBC, Seido Capital.
About
We develop bispecific antibodies that exploit the potential of the natural immune system. Our Amplify•R platform amplifies and redirects endogenous cytokine signaling instead of recombinant cytokines. We avoid issues such as systemic toxicity, immunogenicity and manufacturing concerns.
Startup
Sector:
Biotech
Life Science
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
